Pleomorphic xanthoastrocytoma (PXA) generally occurs in children and young adults and is classified as a low-grade astrocytic tumor with a potential favorable prognosis. But these data must be interpreted with much caution, because of some rapid progression or malignant transformation during the postoperative follow-up. We report herein a rare case of a cerebellar PXA manifested as a benign lesion at first time in a 39 year-old woman, but with malignant transformation two years later. In this paper, we discuss the clinical signs, radiological findings and the therapeutic data on the subject according to literature review.
Introduction
Pleomorphic xanthoastrocytoma (PXA), first described by Kepes et al. in 1979, is a rare neoplasm that accounts for less than 1% of all astrocytic tumors [1] . It had been considered as a low-grade astrocytic tumor with a relatively favorable prognosis compared to other astrocyte-derived tumors, and is classified as grade II in the World Health Organization (WHO) classification [1] [2] . But this situa- [5] . In this paper, we report a well-documented case of a malignant transformation of a cerebellar PXA with poor prognosis and we discuss the clinical course, surgical management and therapeutic findings on this special case.
Case Report
This 39 year-old woman, with no medical history, was admitted in our department for headache, vomiting and gait disturbance six months ago. Neurological examination only found a slight cerebellar ataxia with increased deep and superficial reflex. There was no deficit and no papilledema in ophtalmological test. A cranial CT scan showed a cystic midline isodense cerebellar lesion enhanced by contrast injection (Figure 1(a) ). She underwent a midline suboccipital craniectomy procedure that allowed to a wholly gross total resection ( Figure 1(b) ). Histological examination of surgical specimen confirmed a diagnosis of PXA without anaplasia. She was discharged on the tenth postoperative day without any complications. A second postoperative CT scan 8 months later shown no evidence of recurrence (Figure 1(c) ). But, two years after the first surgery, she had been readmitted in emergency with the same clinical symptoms associated with vertigo and intermittent visual (Figure 2(b) ). So, the patient was discharged with the advice for further radiotherapy. But two months later, she was received in severe cachexia and high nuchal rigidity. No radiotherapy had been done in our case. CT scan showed a recurrence of the mass that is large in size from all the posterior fossa to the supratentorial area. Due to the rapid progression of the tumor and the lack of therapeutic treatment options available to us, we decided to stop treatment after discussions with her family. She died three days later (Figure 2(c) ).
Discussion
PXA is a low-grade astrocytoma that corresponds to a WHO grade II [6] . The majority of PXA cases occur in a supratentorial location within the temporal followed by parietal, frontal and occipital lobes [7] [8]. However, pure cerebellar PXA are very rare. Only 16 cases of cerebellar PXA had been related in the literature from which three had a malignant transformation ( Table 1 ). The time from diagnosis to malignancy features was approximately 24 months in our case. Cerebellar PXA was more prevalent in females. Two-thirds of cerebellar PXAs occurred in adults and the average age at the time of diagnosis was 33 years. In contrast, supratentorial forms were observed in patients with a younger average age (21 -26 years) [3] [4].
The main clinical signs in our case were headache, vomiting, and gait disturbance. . Chemotherapy has not been adequately studied [19] . The clinical course of patients with histologically malignant PXA was often more favorable and less precipitous than that of the patients with fibrillary astrocytomas that showed the same features [2] . Analysis of the published data reveals that the 5-year survival rate for the patients harboring ''typical'' PXA is approximately 80%. None of the patients with ''atypical'' PXA have been reported to survive for more than 3 years with or without adjuvant therapies. Our patient had no adjuvant therapy after the second operation and the tumor made a rapid progression within all the posterior fossa with supratentorial extension during a very short time. We stopped our investigation and the patient died a few days later.
Conclusion
Cerebellar PXA with malignant transformation is rarely observed, with only 03 fatal cases including ours reported in the literature. The prognosis is very poor compared to supratentorial locations despite the use of adjuvant therapeutic tools after surgery. None of the patients suffering from PXA with malignant transformation has been reported to survive more than three years. As such, the initial diagnosis of this fatal progression of PXA must be established correctly.
